DIA Bioventure Day

Is the current Bioventure paradigm delivering return for patients and investors? This is the key question to be addressed by stakeholders from the funding, and from the innovating side.

戻る Agenda

EMA Health Care Pipeline White Spots Analysis – Opportunities for BioVentures?

Speaker(s)

Agnès Saint-Raymond, DrMed

European Medicines Agency, Netherlands

Head of Division International Affairs

DIA Bioventure Day

EMA Health Care Pipeline White Spots Analysis – Opportunities for BioVentures?

Speaker(s)

Agnès Saint-Raymond, DrMed

最新情報や機会を逃さないで